Top

29-04-2015 | Head and neck cancers | ReviewPaper | Article

Impact of weight loss in patients with head and neck carcinoma undergoing radiotherapy: is it an underestimated phenomenon? A radiation oncologist’s perspective

Authors: J Cacicedo, A Dal Pra, F Alongi, A Navarro

Abstract

Eur J Clin Nutr 2015; 69: 757–760. doi:10.1038/ejcn.2015.65

Nutrition is a crucial topic in oncology, a worsening in nutritional status being able to influence both the course of the disease and its outcome. Malnutrition is a pathological state characterized by an inadequate intake of energy and/or nutrients to meet the biological needs of the body, leading to a systemic catabolic state with potentially reversible changes in body composition and function.¹ Weight loss, one of the most characteristic signs of malnutrition, is a common finding in patients with head and neck (HN) cancer and is associated with poor prognosis.^2, 3 During radiotherapy (RT) and chemoradiotherapy, the percentage of malnourished patients rises to 44–88%.³ Moreover, critical weight loss (>5% from the start of RT until week 8 or >7.5% until week 12)⁴ in HN patients may be seen in as high as 57% of patients.¹ Therefore, there is a need to assess the role of nutritional support in the comprehensive management of these patients. Here we briefly outline the current lack of consensus on this issue and why more high-quality studies are required.

1. Langius JA, Bakker S, Rietveld DH, Kruizenga HM, Langendijk JA, Weijs PJ et al. Critical weight loss is a major prognostic indicator for disease-specific survival in patients with head and neck cancer receiving radiotherapy. Br J Cancer 2013; 109: 1093–1099.

2. Ravasco P, Monteiro-Grillo I, Marques VP, Camilo ME. Impact of nutrition on outcome: a prospective randomized controlled trial in patients with head and neck cancer undergoing radiotherapy. Head Neck 2005; 27: 659–668.

3. Langius JA, Zandbergen MC, Eerenstein SE, van Tulder MW, Leemans CR, Kramer MH et al. Effect of nutritional interventions on nutritional status, quality of life and mortality in patients with head and neck cancer receiving (chemo)radiotherapy: a systematic review. Clin Nutr 2013; 32: 671–678.

4. White JV, Guenter P, Jensen G, Malone A, Schofield M. Consensus statement: Academy of Nutrition and Dietetics and American Society for Parenteral and Enteral Nutrition: characteristics recommended for the identification and documentation of adult malnutrition (undernutrition). JPEN J Parenter Enteral Nutr 2012; 36: 275–283.

5. Isenring EA, Capra S, Bauer JD. Nutrition intervention is beneficial in oncology outpatients receiving radiotherapy to the gastrointestinal or head and neck area. Br J Cancer 2004; 91: 447–452.

6. Basch E, Abernethy AP, Mullins CD, Reeve BB, Smith ML, Coons SJ et al. Recommendations for incorporating patient-reported outcomes into clinical comparative effectiveness research in adult oncology. J Clin Oncol 2012; 30: 4249–4255.

7. Bourhis J, Overgaard J, Audry H, Ang KK, Saunders M, Bernier J et al. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Lancet 2006; 368: 843–854.

8. Pignon JP, le Maître A, Maillard E, Bourhis J. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol 2009; 92: 4–14.

9. Nourissat A, Bairati I, Samson E, Fortin A, Gélinas M, Nabid A et al. Predictors of weight loss during radiotherapy in patients with stage I or II head and neck cancer. Cancer 2010; 116: 2275–2283.

10. Cacicedo J, Casquero F, Martinez-Indart L, del Hoyo O, Gomez de Iturriaga A, Navarro A et al. A prospective analysis of factors that influence weight loss in patients undergoing radiotherapy. Chin J Cancer 2014; 33: 204–210.

11. Russi EG, Corvò R, Merlotti A, Alterio D, Franco P, Pergolizzi S et al. Swallowing dysfunction in head and neck cancer patients treated by radiotherapy: review and recommendations of the supportive task group of the Italian Association of Radiation Oncology. Cancer Treat Rev 2012; 38: 1033–1049.

12. August DA, Huhmann MB. A.S.P.E.N. clinical guidelines: nutrition support therapy during adult anticancer treatment and in hematopoietic cell transplantation. JPEN J Parenter Enteral Nutr 2009; 33: 472–500.

13. Arends J, Bodoky G, Bozzetti F, Fearon K, Muscaritoli M, Selga G et al. ESPEN Guidelines on enteral nutrition: non-surgical oncology. Clin Nutr 2006; 25: 245–259.

14. Piquet MA, Ozsahin M, Larpin I, Zouhair A, Coti P, Monney M et al. Early nutritional intervention in oropharyngeal cancer patients undergoing radiotherapy. Support Care Cancer 2002; 10: 502e4.

15. Rutter CE, Yovino S, Taylor R, Wolf J, Cullen KJ, Ord R et al. Impact of early percutaneous endoscopic gastrostomy tube placement on nutritional status and hospitalization in patients with head and neck cancer receiving definitive chemoradiation therapy. Head Neck 2011; 33: 1441e7.

16. Nugent B, Lewis S, O’Sullivan JM. Enteral feeding methods for nutritional management in patients with head and neck cancers being treated with radiotherapy and/or chemotherapy. Cochrane Database Syst Rev 2013; 1: CD007904.

17. Brown TE, Spurgin AL, Ross L, Tripcony L, Keller J, Hughes BG et al. Validated swallowing and nutrition guidelines for patients with head and neck cancer: identification of high-risk patients for proactive gastrostomy. Head Neck 2013; 35: 1385–1391.

18. Jack DR, Dawson FR, Reilly JE, Shoaib T. Guideline for prophylactic feeding tube insertion in patients undergoing resection of head and neck cancers. J Plast Reconstr Aesthet Surg 2012; 65: 610–615.

19. Langius JAE, Doornaert P, Spreeuwenberg MD, Langendijk JA, Leemans CR, Schueren MA. Radiotherapy on the neck nodes predicts severe weight loss in patients with early stage laryngeal cancer. Radiother Oncol 2010; 97: 80–85.

20. Pfister DG, Ang KK, Brizel DM, Burtness BA, Busse PM, Caudell JJ et al. Head and neck cancers, version 2.2013. Featured updates to the NCCN guidelines. J Natl Compr Canc Netw 2013; 11: 917–923.

21. Li B, Li D, Lau DH, Farwell DG, Luu Q, Rocke DM et al. Clinical-dosimetric analysis of measures of dysphagia including gastrostomy-tube dependence among head and neck cancer patients treated definitively by intensity-modulated radiotherapy with concurrent chemotherapy. Radiat Oncol 2009; 4: 52.

22. Caglar HB, Tishler RB, Othus M, Burke E, Li Y, Goguen L et al. Dose to larynx predicts for swallowing complications after intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 2008; 72: 1110–1118.

23. Mazzola R, Ricchetti F, Fiorentino A, Fersino S, Giaj Levra N, Naccarato S et al. Dose-volume-related dysphagia after constrictor muscles definition in head and neck cancer intensity-modulated radiation treatment. Br J Radiol 2014; 87: 20140543.

24. Mortensen HR, Jensen K, Aksglæde K, Behrens M, Grau C. Late dysphagia after IMRT for head and neck cancer and correlation with dose-volume parameters. Radiother Oncol 2013; 107: 288–294.

25. Levendag PC, Teguha DN, Voet P, van der Esta H, Noever I, de Kruijfa WJ et al. Dysphagia disorders in patients with cancer of the oropharynx are significantly affected by the radiation therapy dose to the superior and middle constrictor muscle: a dose-effect relationship. Radiother Oncol 2007; 85: 64–73.

26. Dirix P, Abbeel S, Vanstraelen B, Hermans R, Nuyts S. Dysphagia after chemoradiotherapy for head-and-neck squamous cell carcinoma: dose–effect relationships for the swallowing structures. Int J Radiat Oncol Biol Phys 2009; 75: 385–392.

27. Schwartz DL, Hutcheson K, Barringer D, Tucker SL, Kies M, Holsinger FC et al. Candidate dosimetric predictors of long-term swallowing dysfunction after oropharyngeal intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 2010; 78: 1356–1365.

28. Wopken K, Bijl HP, van der Schaaf A, van der Laan HP, Chouvalova O, Steenbakkers RJ et al. Development of a multivariable normal tissue complication probability (NTCP) model for tube feeding dependence after curative radiotherapy/chemo-radiotherapy in head and neck cancer. Radiother Oncol 2014; 113: 95–101.

29. Vlacich G, Spratt DE, Diaz R, Phillips JG, Crass J, Li CI et al. Dose to the inferior pharyngeal constrictor predicts prolonged gastrostomy tube dependence with concurrent intensity-modulated radiation therapy and chemotherapy for locally-advanced head and neck cancer. Radiother Oncol 2014; 110: 435–440.

30. Grant DG, Bradley PT, Pothier DD, Bailey D, Caldera S, Baldwin DL et al. Complications following gastrostomy tube insertion in patients with head and neck cancer: a prospective multi-institution study, systematic review and meta-analysis. Clin Otolaryngol 2009; 34: 103–112.

31. Ho KF, Marchant T, Moore C, Webster G, Rowbottom C, Penington H et al. Monitoring dosimetric impact of weight loss with kilovoltage (kV) cone beam CT (CBCT) during parotid-sparing IMRT and concurrent chemotherapy. Int J Radiat Oncol Biol Phys 2012; 82: e375–e382.

32. Jensen AD, Nill S, Huber PE, Bendl R, Debus J, Münter MW. A clinical concept for interfractional adaptive radiation therapy in the treatment of head and neck cancer. Int J Radiat Oncol Biol Phys 2012; 82: 590–5966.

33. Grégoire V, Jeraj R, Lee JA, O'Sullivan B. Radiotherapy for head and neck tumours in 2012 and beyond: conformal, tailored, and adaptive? Lancet Oncol 2012; 13: e292–e300.

34. Dawson LA, Sharpe MB. Image-guided radiotherapy: rationale, benefits, and limitations. Lancet Oncol 2006; 7: 848–858.

35. Alongi F, Di Muzio N. Image-guided radiation therapy: a new era for the radiation oncologist? Int J Clin Oncol 2009; 14: 568–569.

36. Lee C, Langen KM, Lu W, Haimerl J, Schnarr E, Ruchala KJ et al. Assessment of parotid gland dose changes during head and neck cancer radiotherapy using daily megavoltage computed tomography and deformable image registration. Int J Radiat Oncol Biol Phys 2008; 71: 1563–1571.

37. Denaro N, Merlano MC, Russi EG. Dysphagia in head and neck cancer patients: pretreatment evaluation, predictive factors, and assessment during radio-chemotherapy, recommendations. Clin Exp Otorhinolaryngol 2013; 6: 117–126.

38. Ehrsson YT, Hellström PM, Brismar K, Sharp L, Langius-Eklöf A, Laurell G. Explorative study on the predictive value of systematic inflammatory and metabolic markers on weight loss in head and neck cancer patients undergoing radiotherapy. Support Care Cancer 2010; 18: 1385–1391.

Medicine Matters Oncology

Abstract